Certified by Founder Lodge
BiomedVC
Switzerland - Basel
INVESTOR
1 Disclosed Funding Rounds $20,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We put health at the heart of our work. Biomed is a leading Swiss early-stage VC at the center of European biotech. We build companies around the most intriguing innovation. We strive to enab
| Company | Date | Round | Raised |
|---|---|---|---|
 T-CURX GmbH |
December, 18 ,2025 | Series A | $20,000,000 |
 iDEL Therapeutics GmbH |
March, 18 ,2026 | Seed | $10,381,635 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Latent | $80,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Avtal | $24,000,000 | (Mar 20, 2026)
